Mirae Asset Global Etfs Holdings Ltd. Citius Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 68,334 shares of CTXR stock, worth $30,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,334Holding current value
$30,750% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CTXR
# of Institutions
70Shares Held
30.6MCall Options Held
24.7KPut Options Held
0-
Armistice Capital, LLC New York, NY10.2MShares$4.57 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.33MShares$2.85 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$921,9870.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$845,5280.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$812,5760.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $65.8M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...